Aileron Therapeutics, Inc. (ALRN)
NASDAQ: ALRN · IEX Real-Time Price · USD
2.760
-0.040 (-1.43%)
Jul 2, 2024, 4:30 PM EDT - Market closed
Aileron Therapeutics Analyst Ratings
Total Analysts
1
Consensus Rating
Strong Buy
Price Target
$19.00
Upside
+588.41%
Ratings History
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
Ladenburg Thalmann | Ladenburg Thalmann | Strong Buy Maintains $9 → $19 | Strong Buy | Maintains | $9 → $19 | +588.41% | Apr 18, 2024 |
Ladenburg Thalmann | Ladenburg Thalmann | Hold → Strong Buy Upgrades $9 | Hold → Strong Buy | Upgrades | $9 | +226.09% | Dec 1, 2023 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $40 → $20 | Strong Buy | Maintains | $40 → $20 | +624.64% | Jun 30, 2022 |
William Blair | William Blair | Buy → Hold Downgrades n/a | Buy → Hold | Downgrades | n/a | n/a | Jun 29, 2022 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains n/a | Strong Buy | Maintains | n/a | n/a | Mar 31, 2020 |
Canaccord Genuity | Canaccord Genuity | Strong Buy Maintains n/a | Strong Buy | Maintains | n/a | n/a | Apr 9, 2019 |
Jefferies | Jefferies | Strong Buy Initiates n/a | Strong Buy | Initiates | n/a | n/a | Jul 24, 2017 |
B of A Securities | B of A Securities | Strong Buy Initiates n/a | Strong Buy | Initiates | n/a | n/a | Jul 24, 2017 |
Canaccord Genuity | Canaccord Genuity | Strong Buy Initiates n/a | Strong Buy | Initiates | n/a | n/a | Jul 24, 2017 |